Tevas weak pipeline hit by Tourettes drug trial failure
Teva’s weak pipeline hit by Tourette’s drug trial failure
06:21 EST 20 Feb 2020 |
PMLIVE
Drug wasn't able to improve on placebo
Original Article: Teva’s weak pipeline hit by Tourette’s drug trial failure
More From BioPortfolio on "Teva’s weak pipeline hit by Tourette’s drug trial failure"